Inside BioThrust: The Startup Scaling Cell Therapy with Bubble-Free Bioreactors

In this episode of Biology Career Insights, we sit down with Patrick Bongartz, Co-Founder and CEO of BioThrust, a biotech startup revolutionizing cell culture processes with its patented bubble-free, low-shear bioreactor technology.Patrick takes us through his inspiring journey—from his academic foundation at RWTH Aachen University to founding BioThrust in 2020, and how he and his co-founders tackled key challenges in bioprocessing. We talk about the technical innovation behind their ComfyCell system, the evolution of cell and gene therapy, and what it means to build a startup in today’s complex biotech landscape.This candid conversation covers:Patrick’s academic and entrepreneurial backgroundThe story and mission behind BioThrustDeep dive into bioprocessing innovation: bubble-free aerationTrends in MSC, CAR-T, and HEK scale-upInsights from ISCT and ASGCT 2025 conferencesReflections on co-founder dynamics, fundraising, and navigating uncertainty in biotechAdvice for aspiring scientists and biotech entrepreneurs✨ A huge thanks to Patrick for generously sharing his story and insights!🔔 Subscribe for more conversations with biotech leaders: https://youtube.com/@bcipodcast 📩 Learn more or get in touch: www.bcipodcast.eu

There are no comments yet.

Please log in to write the first comment.